Letter From the Editor
Letter From the Editor: Addressing the Racial Gap in Health Care
Feature Article
Treatment of Unresectable and Resectable Stage IV Colorectal Cancer
Abstract: Colorectal cancer is the third most commonly diagnosed cancer in the United States. Approximately 20% of patients have metastatic disease at diagnosis, and a proportion […]
In This Issue
From Recent Issues
Counterpoints
Does Combination Menopausal Hormone Therapy Increase the Risk of Breast Cancer?
In 2002, researchers from the Women’s Health Initiative (WHI) reported that menopausal hormone therapy (MHT) increases the risk of breast cancer. This widely publicized finding led […]
Feature Article
Refining the Standard of Care in Immune Thrombotic Thrombocytopenic Purpura
Abstract: Acute immune thrombotic thrombocytopenic purpura (iTTP) is a medical emergency. In the setting of any thrombotic microangiopathy (TMA), blood should be drawn to measure ADAMTS13 […]
Feature Article
Management Options for Node-Positive Muscle-Invasive Bladder Cancer
Abstract: Localized node-positive bladder cancer is characterized by a high degree of heterogeneity, leading to significant variability in overall survival outcomes among affected individuals. The absence […]
Supplements
Managing Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Shared-Care Approach to Combination Therapy
Abstract: The treatment landscape for metastatic hormone-sensitive prostate cancer has evolved significantly over the past decade. Androgen deprivation therapy (ADT) was once the first-line standard of care, […]
Chronic lymphocytic leukemia
Highlights in Chronic Lymphocytic Leukemia From the 65th ASH Annual Meeting and Exposition
A Review of Selected Presentations From ASH 2023 December 9-12, 2023 • San Diego, California Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic […]
Metastatic Breast Cancer
Highlights in Metastatic Breast Cancer From the 2023 San Antonio Breast Cancer Symposium
A Review of Selected Presentations From SABCS 2023 December 5-9, 2023 • San Antonio, Texas Clinical Outcomes by Age Subgroups in the Phase 3 TROPiCS-02 […]